ArticleCell death & disease2023

ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE.

Praveen Guruvaiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.